Noninvasive indicators of atherosclerosis in subclinical hypothyroidism

Ismail Dogu Kilic1, Halil Tanriverdi, Semin Fenkci

  • 1Department of Cardiology, Pamukkale University School of Medicine, Denizli, Turkey.

Insights

Subclinical hypothyroidism (SCH) is linked to endothelial dysfunction, indicated by reduced flow-mediated dilation (FMD). While carotid intima-media thickness and aortic distensibility showed no significant differences, FMD highlights SCH

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • The cardiovascular system possesses numerous thyroid hormone receptors, making it a primary site for thyroid hormone action.
  • The precise impact of subclinical hypothyroidism (SCH) on the development of atherosclerosis remains unclear.
  • Subclinical hypothyroidism is characterized by elevated thyroid-stimulating hormone (TSH) with normal serum T4 and T3 levels.

Purpose of the Study:

  • To investigate the association between subclinical hypothyroidism and atherosclerosis.
  • To compare vascular parameters, including carotid intima-media thickness (CIMT), flow-mediated dilation (FMD), and aortic distensibility, between individuals with and without SCH.

Main Methods:

  • A case-control study involving 32 patients with SCH and 29 healthy controls.
  • Assessment of vascular function using flow-mediated dilation (FMD) and GTN-induced vasodilation.
  • Measurement of carotid intima-media thickness (CIMT) and aortic distensibility.

Main Results:

  • Patients with SCH exhibited significantly lower flow-mediated dilation (FMD) compared to controls.
  • No statistically significant differences were observed in carotid intima-media thickness (CIMT) or aortic distensibility between the SCH group and the control group.
  • GTN-induced vasodilation, a measure of smooth muscle function, was comparable in both groups.

Conclusions:

  • Subclinical hypothyroidism is associated with endothelial dysfunction, as evidenced by impaired FMD.
  • The discrepancies in CIMT and aortic stiffness findings may stem from these parameters reflecting structural changes, whereas FMD offers a dynamic assessment of endothelial function influenced by acute and chronic factors.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...